Naringenin can significantly inhibit the growth of human gastric cancer cells (SGC-7901), reduce the expression of MMP-2 and MMP-9 in gastric cancer cells, and significantly suppress the proliferation, adhesion, invasion, and migration of SGC-7901 [58]. This evidence concerns the gene MMP2 and gastric cancer.